Trial
NCT03436420
Gemcabene for the Treatment of Pediatric NAFLD
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Emory University
Collaborators
Gemphire Therapeutics
Condition
Non-Alcoholic Fatty Liver Disease
Intervention
Gemcabene
Why stopped
Terminated due to lack of efficacy and safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-31